in the family Hepeviridae are zoonotic. Recently, a genotype 4 HEV was reportedly detected in fecal samples of cows, although independent confirmation is lacking. In this study, we first tested serum samples from 983 cows in different regions in the United States for the presence of immunoglobulin G (IgG) anti-HEV and found that 20.4% of cows were seropositive. The highest seroprevalence rate (68.4%) was from a herd in Georgia. In an attempt to genetically identify HEV in cattle, a prospective study was conducted in a known seropositive dairy herd by monitoring 10 newborn calves from birth to 6 months of age for evidence of HEV infection. At least 3 of the 10 calves seroconverted to IgG anti-HEV, and importantly the antibodies presented neutralized genotype 3 human HEV, thus, indicating the specificity of IgG anti-HEV in the cattle. However, our extensive attempts to identify HEV-related sequences in cattle using broad-spectrum reverse transcription-polymerase chain reaction assays and MiSeq deep-sequencing technology failed. The results suggest the existence of an agent antigenically related to HEV in cattle, although, contrary to published reports, we showed that the IgG recognizing HEV in cattle was not caused by HEV infection. wileyonlinelibrary.com/journal/jmv
| INTRODUCTION
Hepatitis E virus (HEV), the causative agent of hepatitis E, is transmitted via fecal-oral route through contaminated water and food. 1 Hepatitis E is a global disease with large waterborne outbreaks occurring in developing countries because of poor sanitation conditions. In industrialized countries, sporadic and cluster cases of hepatitis E because of the ingestion of contaminated animal meats and shellfish or direct contact with infected animals have also been reported. 2 The overall mortality rate associated with HEV infection ranges from 0.5% to 4% in immunocompetent individuals; however, concurrent pregnancy accounts for increases in mortality up to 28%. 3, 4 Immunocompromised individuals infected with HEV, such as organ transplant recipients, 5 patients with lymphoma and leukemia, 6, 7 or patients with HIV infection, 8 tend to progress into chronicity. 9 HEV is a recognized zoonotic agent with numerous known animal reservoirs. 10 Among the well-characterized animal strains of HEV are the genotypes 3 and 4 swine HEV within species Orthohepevirus A in domestic and wild pigs 11, 12 and the genotypes 1 to 4 avian HEV within species Orthohepevirus C in chickens. 13, 14 The recent identification of genetically diversified strains of HEV across a wide range of animal species, including bat, 15 fish, 16 rat, 17 ferret, 18 rabbit, 19 wild boar, 12 moose, 20 mongoose, 21 deer, 22 and camel, 23 greatly expanded the host range and diversity of the virus. Ruminant species, including deer, 22 goats, 24 sheep, and cattle, 25 have been implicated as a potential reservoir as either immunoglobulin G (IgG) anti-HEV or viral RNA has been detected in these species. In 2016, genotype 4 HEV RNA was reportedly detected in cows in China, and raw milk was shown to be contaminated with infectious HEV. 26 Surprisingly, the HEV sequence from cows was more than 99% identical across the entire genome to the HEV sequences from humans and pigs in China. 26 Likewise, Yan et al 27 reported the detection of genotype 4 HEV RNA from sera in 8 of 254 yellow cattle in China, with up to 96.6% sequence homology to a Chinese human HEV strain. However, independent confirmation of these reports is still lacking. For example, two recent studies failed to identify HEV RNA in milk or fecal samples of cows in Belgium 28 or Germany. 29 Therefore, the main objective of this study was to determine if cattle in the United
States are infected with HEV. 
| MATERIALS AND METHODS

| Bovine serum samples
| A prospective field study to genetically identify HEV in calves
In an attempt to genetically identify HEV in cows, we conducted a prospective study in a known HEV IgG seropositive university dairy herd in Virginia, by following 10 newborn calves from birth to 6 months of age when they were moved to pasture. Weekly blood and fecal samples were collected from each of the 10 calves. Newborn calves were housed in individual hutches until 12 weeks of age when they were moved to group barn housing under the standard operating procedures at this farm. The weekly serum and fecal samples were tested for the presence of HEV RNA by a nested universal reverse transcription-polymerase chain reaction (RT-PCR)
assay that is capable of detecting genotypes 1 to 4 HEV strains (Supporting Information Table S1 ), and the weekly serum samples were also tested by a commercial enzyme-linked immunosorbent assay (ELISA) kit (Wantai, Beijing, China) for the presence of IgG anti-HEV ( Figure 1 ). In addition, the serum levels of liver enzymes, including gamma-glutamyl transferase (GGT), glutamate dehydrogenase (GLDH), and aspartate aminotransferase (AST), were also measured ( Figure 2 ). All sera were tested by an established commercial ELISA assay (Wantai ELISA kit). Individual ELISA S/CO value greater than 1.0 is considered positive.
| Collection of environmental samples from an HEV IgG positive dairy farm
A total of 100 environmental samples were collected from an HEV IgG seropositive dairy farm in Virginia and stored at −80°C until testing. These included fresh composite fecal samples from the milking parlor floor, pastures, floors and bedding from cow and calf barns, runoff water, and fecal samples from the waste collection tanks of the associated barns, and standing pools of cleaning water.
All environmental samples were tested for the presence of HEV RNA by a broad-spectrum nested RT-PCR assay.
| ELISA to detect IgG anti-HEV in bovine sera
The bovine serum samples were tested for IgG anti-HEV using the following the manufacturerʼs instructions and the quality control criteria.
Serum samples with S/CO greater than 1.0 were considered positive for IgG-binding HEV. Results were declared borderline when S/CO between 0.9 and 1.1 was measured, and these samples were retested for confirmation. Samples with S/CO less than 1.0 were declared negative for IgG-binding HEV. All sera from herds from different states (Table 1) , the Virginia dairy milking herd (Table 1) , and the intensively studied calves and their respective dams (Table 2) were tested for the presence of IgG-binding HEV by ELISA (Figure 1 ).
| Serum level of liver enzyme analyses
All sera from the calves in the prospective study (ID #'s 5078, 5079, 5080, 5081, 5082, 5083, 5084, 5086, 5088, and 5091) were tested by the Cornell Animal Health Diagnostic Center (AHDC) (Ithaca, NY) using standard methods for serum levels of liver enzymes, including GGT, GLDH, and AST. Reference intervals of each enzyme specifically for bovine as determined by Cornell AHDC are as follows: AST 61 to 162 U/L, GLDH 11 to 83 U/L, and GGT 9 to 50 U/L ( Figure 2 ).
| Broad-spectrum nested RT-PCR assays to detect HEV RNA in bovine samples
Selected serum, fecal, and environmental samples were tested for the presence of HEV, using a broad-spectrum RT-PCR assay that is known to detect RNA of multiple HEV genotypes, as previously described. 31 In addition, degenerate primer sets were also designed on the basis of the alignment of known HEV strains (Supporting Information Table S1 ) and used for the detection of HEV RNA in the same nested RT-PCR assay. Table S1 ) using AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, CA).
For the serum samples from calves in the prospective study, an additional heminested touchdown RT-PCR was used with degenerate primers, BatHEVF4228 and BatHEVR4598 (Supporting Information   Table S1 ), according to the published protocol. 15 The second round of the nested RT-PCR was completed using 5μL of first-round DNA product as the template and degenerate primers BatHEVF4228 and BatH-EVR4565 (Supporting Information Table S1 ). 15 
| In vitro neutralization assay for HEV
A subclone of the Huh7 human liver cell line, Huh7-S10-3, 33 was used to propagate the genotype 3 human HEV Kernow P6 strain. 34 Human hepatocellular carcinoma cells HepG2/C3A (ATCC, Manassas, VA) were maintained in Dulbecco's modified Eagle medium (DMEM, ThermoFisher Scientific, Ontario, Canada) with 10% fetal bovine serum on collagen-coated flasks and were used for all in vitro infectivity assays as described previously 35, 36 on selected bovine sera that were tested positive by ELISA. Briefly, the genotype 3 HEV Kernow P6 virus stock 37 to generate a value for the overall percentage decrease in HEV infectivity, which represented the ability of the bovine serum to neutralize genotype 3 human HEV. Sera were scored as effective if there was more than 50% reduction in infectivity and were further titered at 1:2 to 1:8192 serial dilutions using the same procedure ( 
| Seroconversion to IgG-binding HEV antigen in serum of calves from a prospective study in a Virginia dairy herd
For the prospective study in a dairy herd, the 10 female calves were born from both seropositive dams (#'s 4682, 4810, and 4700) and seronegative dams (#'s 4832, 4855, 4517, 4854, 4852, 4686, and 4344) ( Table 2) . Calf numbers 5079, 5080, 5081, 5084, and 5088 did not seroconvert to HEV at any time point during the study and were considered negative ( Figure 1A) . Calf numbers 5078, 5082, and 5091 had varying levels of seroconversion. Calf number 5078 briefly seroconverted by producing IgG recognizing HEV at 31 days of age for 1 week and again at the age of 71 days for 2 weeks with a relatively low level of antibody ( Figure 1B ). Calf #5082 briefly seroconverted at 28 days of age for 1 week and again at 78 days of age with a high level of IgG recognizing HEV, observed and lasting 9
weeks. Calf #5091 seroconverted at 106 days of age with a high level of HEV IgG observed for 3 weeks. The remaining two calves 5083
and 5086 had only transient seroconversion with very low levels of antibodies ( Figure 1B ).
The prospective study ended with the movement of calves to pasture at 6 months of age. None of the 10 calves was positive for maternal IgG anti-HEV at the time of birth or within the first 3 weeks after birth (Table 2) . Dam numbers 4682, 4700, and 4810, F I G U R E 3 Correlation between seroconversion and serum levels of GLDH in serum samples collected prospectively from calves from the time of birth to 6 months of age. Calves (A) #5078, (B) 5082, (C) 5083, (D) 5086, and (E) 5091 seroconversion to IgG anti-HEV correlated with the elevations in serum levels of GLDH. The specific signal (individual ELISA OD) values were plotted as S/CO (left y-axis) as a function of the age of the animal (days after birth). The ELISA cut-off value indicating seropositivity to IgG anti-HEV is indicated as a dotted line at 1.0 based on the commercial Wantai ELISA assay standard. The serum levels of GLDH were plotted (right y-axis) as a function of the age of the animal (days after birth). The upper normal limit was provided with the analysis based on the diagnostic laboratoryʼs standard for GLDH in bovine species and indicated as the dotted line at 83 U/L. CO, cut-off value; ELISA, enzyme-linked immunosorbent assay; GLDH, glutamate dehydrogenase; IgG, immunoglobulin G; OD, optical density; S, optical density corresponding to calf numbers 5086, 5088, and 5091, had HEV IgG within 2 weeks before calving. No correlation between the seropositive dams and the seroconversion of calves was observed in this study (Table 2 ). were used for the RT-PCR assays. Furthermore, published RT-PCR primers and protocols used for recent detection of bat, 15 rat, 31 and rabbit HEV 32 strains, and degenerate pan-primers used for the detection of multiple HEV genotypes were also used in our repeated attempts to amplify HEV RNA (Supporting Information   Table S1 ). Serum and fecal samples used for these RT-PCR assays included three calves (ID no 5078, 5082, and 5091) that had at all time points, but did not identify any HEV-related sequence.
|
Sequences from numerous other viruses were identified in the serum and fecal samples of both the calves (data not shown), 41 indicating that the MiSeq deep-sequencing technique was successfully applied.
Furthermore, MiSeq deep sequencing was performed on a pooled serum sample from all time points of all 10 calves in the prospective study, again any HEV-related sequence was not detected. Finally, we performed MiSeq deep sequencing on a combined serum sample from a total of 100 cattle randomly selected from 9 different states, and again HEV-related sequence was not identified. (Table 3) , respectively, consistently reduced the infection of genotype 3 human HEV by more than 50% (Table 3) .
Reductions of approximately 50% corresponded with virus neutra- animal origins. 5, 42 Since the discovery of swine HEV from pigs in the United States in 1997, 11 genotypes 3 and 4 HEV have been detected worldwide in both wild and domestic swine. 43 The ubiquitous nature of swine HEV in pigs worldwide has led to the contamination of pork products, including in the United States, 44 The Netherlands, 45 the United Kingdom, 46 and Japan. 47 Foodborne transmission of swine HEV has been definitively linked to the consumption of raw or undercooked pork products. 45 The known host range of HEV is rapidly expanding with the genetic identification of novel HEV strains in a wide range of species.
HEV IgG has also been identified in several other species, including 43, 48 We also tested 213 sequential serum samples collected from 38 cows in Georgia over a period of 9 months and found that 68.4% of the cows were seropositive at least once during that period, which is similar to the levels observed in some swine herds. 49, 50 The results suggest that there is an HEV-related agent in the bovine population.
In our attempt to genetically identify HEV in cattle, we conducted a prospective study in a known HEV-seropositive dairy herd by monitoring 10 newborn calves from the time of birth to 6 months of age for evidence of HEV infection. We showed that at least 3 of the 10 calves temporarily seroconverted to IgG against HEV at different time points during the course of the prospective study, suggesting that an HEV-related agent is present in these calves. Importantly, we demonstrated that the IgG anti-HEV present in the seropositive calves shows some neutralizing activity against the genotype 3 human HEV.
This indicates that HEV IgG present in the cattle can target antigenic epitopes found on HEV. Interestingly, the serum level of liver enzyme GLDH appears to correlate with the seroconversion to HEV IgG in the calves. This is suggestive of potential liver damage associated with infection by the HEV-related agent.
Our repeated and extensive attempts to genetically identify the source of seropositivity in the cattle were unsuccessful. Both HEVspecific and broad-spectrum degenerate primers that are known to amplify sequences from multiple HEV genotypes with the species 
CONFLICTS OF INTEREST
The authors declare that they have no conflicts of interest.
ORCID
Xiang-Jin Meng http://orcid.org/0000-0002-2739-1334
